Dr. Arnold Renshaw, from Manchester in England, reported in the Annals of Rheumatic Disease (1947) that he had obtained good results with enzyme treatment of over 700 patients with rheumatoid arthritis, osteoarthritis or Fibrositis. "Some intractable cases of ankylosing spondylitis and Still's disease have also responded to this therapy." He went on to say that of 556 people with various types of arthritis, 283 were found to be much improved, and a further 219 were improved to a less marked extent. Of 292 cases of rheumatoid arthritis, 264 showed improvement of various degrees. The longer the duration of the disease, the longer time before improvement was observed, although most started to show improvement after just two or three months of enzyme therapy.
Despite these favourable findings, digestive enzyme therapy in conventional medicine has been reserved for those diseases that directly result in a pathological deficiency of pancreas-derived digestive enzymes.
What causes it?
There are two main types of arthritis: Osteo-arthritis, which in lay terms is due to wear and tear of the joint, and Rheumatoid arthritis which is a form of arthritis where the joints have become inflamed, possibly as a result of a virus or autoimmune response.
Warning: Rheumatoid vasculitis (inflammation of the blood vessels) is a serious complication of RA and can be life-threatening. It can lead to skin ulcerations (and subsequent infections), bleeding stomach ulcers (which can lead to massive haemorrhage), and neuropathies (nerve problems causing pain, numbness or tingling). Vasculitis may also affect the brain, nerves, and heart causing strokes, sensory neuropathies (numbness and tingling), heart attacks, or heart failure. Use the program with safety but seek medical help at the same time.
In general Osteo-arthritic pain will respond faster to Serrapeptase treatment than rheumatoid arthritis, which may need more intensive treatment. The best results in any studies for rheumatoid arthritis come from those using Enzymes and diet. A new US study showed that a Mediterranean diet showed a substantial improvement and confirms earlier such studies that show processed starchy carbohydrate diets are disease promoting.
Surprisingly, doctors still do not know what actually causes arthritis - whatever the various schools of thought speculate on as to its cause, the one thing we are sure of is that the real problem is that the normal healing function of the body is no longer doing its job of looking after the repair of the damage being caused by the Arthritis.
One of the most important potential benefits of Proteolytic Enzymes is in the treatment of rheumatoid arthritis. Conventional treatment of this devastating disease involves powerful, dangerous drugs, like steroidal and non-steroidal anti-inflammatory drugs, as well as more exotic treatments, such as methotrexate and D-penicillamine. About the best one can say about these drugs is that they may provide a degree of short-term symptomatic relief. At worst, they will kill you.
Numerous studies in animals and people with rheumatoid arthritis indicate that enzyme therapy can manage symptoms of pain and inflammation at least as well as the conventional drugs, but with none of the adverse effects. In fact, side effects with enzymes are virtually nonexistent .
Doctors who are experienced with Proteolytic Enzymes find prophylactic treatment offers a wide range of benefits including:
* Better mobilisation, reducing the degree of muscle atrophy, arthritis and pain on movement
* Less risk of thromboembolic complications
* Less pain and discomfort due to swelling
* Less risk of cartilage or capsular damage due to immobility
How can Serracor-nK and SerraRX80 Help?
Breaking it Down:
How Serrapeptase helps Internal/External Scar Tissue and Adhesions- Serrapeptase helps immensely as it slowly digests all of the dead tissue/scar tissue. By clearing away this problem tissue it enables the body's own healing system to replace it with healthy tissue.
Nattokinase - a well studied enzyme, famous for dissolving blood clots and fibrin in the blood faster than any drug.
Nattokinase Research - Fibrinoyltic Activity
In vitro and in vivo studies have consistently demonstrated the potent fibrinolytic effect of Nattokinase.1 Research with nattokinase demonstrates that it may help avoid or reduce the likelihood of deep vein thrombosis, cardiac infarction, pulmonary emboli and stroke. It appears to accomplish this via its finbrinolytic, anti-inflammatory and modulating effect on blood pressure. Studies on hypertension demonstrate an average drop of 10.9% in Systolic Blood Pressure and a 9.7 percent drop in Diastolic Blood Pressure.2,3,4
A study conducted with natto on 12 healthy adults (6 men and 6 women, between the ages of 21 and 55) sought to demonstrate fibrinolytic activity. The volunteers were given 200 grams of natto (the food) before breakfast, then their fibrinolytic activity was tested over time. The results indicate natto generates an increased ability to dissolve blood clots. As a control, researchers later fed the same amount of boiled soybeans to the same volunteers and tracked their fibrinolytic activity. The tests showed no significant change.5
The accumulation of fibrin in blood vessels significantly increases the likelihood of thrombosis formation resulting in a cardiovascular event. For thrombolytic therapy, microbial fibrinolytic enzymes are now much more accepted. The physiochemical properties of this enzyme is becoming well characterized and its effectiveness in thrombolysis in vivo has been further identified.6,7
Serrapeptase - (Peptizyme SP) is an enzyme derived from a species of bacteria originally found in the intestine of silkworms. The bacteria, Serratia mercesans produces the enzyme that enables the silkworm to dissolve its silken cocoon and emerge after metamorphosis. Serratia is now grown in cultures to produce serrapeptase by fermentation. Numerous research and clinical studies demonstrate serrapeptase's formidable anti-inflammatory, proteolytic (protein dissolving) and fibrinolytic (fibrin dissolving) properties. They also show that scar tissue is greatly reduced and proteins involved in the inflammatory process are effectively digested. Serrapeptase is a protease that has been used in Japan and Europe for over four decades for its anti-inflammatory activity.
BROMELAIN is a collective name for the proteolytic (protein-digesting) enzymes found in the pineapple plant (Ananas comosus), and is known for its digestive as well its anti-inflammatory properties. Because of its activity across a wide pH range, bromelain is a good substitute for pepsin and trypsin for both digestive and systemic support.*
PAPAIN is a widely used enzyme obtained from the latex of the fruit of the Papaya tree (Carica papaya). Papain has been used for centuries as an effective digestive aid.
LIPASE catalyzes the break-down of fats into essential fatty acids that are needed for healthy tissues and cells.*
PROTEASES are enzymes that hydrolyze (break-down) proteins like meat, casein, gelatin, soy, fish and other plant and animal proteins to smaller chains of polypeptides (small proteins) and amino acids for easier uptake throughout the body.
RUTIN is a bioflavonoid that strengthens and tones arteries and veins and provides antioxidant support against free-radicals and inflammation.*
AMLA, or Indian gooseberry (Emblica officinalis), is a natural and efficacious antioxidant. It is one of the richest sources of absorbable vitamin C available.
COENZYME Q10 is an essential enzyme and cofactor in metabolism that is naturally made and stored in the liver, kidneys, and heart. It is a vital part of energy production and overall cell health.*
MAGNESIUM is an essential mineral used as a cofactor by over 350 enzymes in the body. Magnesium is critical part of cardiovascular and nerve physiology. It helps relax arteries and assists in proper nerve impulse function.*
Enteric Coated Serrapeptase ~ 80,000 SU's of Activity Per Capsule ~ Serra RX80is a potent and purified strain of Serrapeptase, also called Serratiopeptidase. Provides Potent Anti-inflammatory & Fibrinolytic Activity*
Cleanses the Circulatory System of Excessive Fibrin*
Supports the respiratory and sinus systems to promote ear, nose and throat health. It helps amend elasticity and viscosity of naturally produced mucus, without causing mucus depletion.*
References 1. Enhancement of the Fibrinolytic Activity in Plasma by Oral Administration of Nattokinases Acta Haematol 1990; 84:139-143. Hiroyuki Sumia, Hiroki Hamadab, Koichiro Nakanishic, Hajime Hiratanic aDepartment of Physiology, Miyazaki Medical College, Miyazaki, Japan; bDepartment of Biochemistry, Oklahoma State University, Okla., USA; cBiochemistry Research Laboratories, JCR Pharmaceuticals, Kobe, Japan
2. Prevent Heart Attack and Stroke with Potent Enzyme that Dissolves Deadly Blood Clots in Hours. Health Sciences Institute, March 2002.
3. Effect of Natto Diet on Blood Pressure. JTTAS, 1995. Maruyama M, Sumi H..
4. Effects of Nattokinase on Blood Pressure: A Randomized, Controlled Trial. Hypertension Research 31, 1583-1588 (2008) Ji Young Kim 1,2, Si Nae Gum2,3, Jean Kyung Paik2,4,5,
5. Purification and Characterization of a Strong Fibrinolytic Enzyme (Nattokinase) in the Vegetable Cheese Natto, a Popular Soybean Fermented Food in Japan. Biochemical and Biophysical Research Communications, Vol. 197, Issue 3, 30 December 1993, pp. 1340-1347 Fujita M., Nomura K., Hong K., Ito Y., Asada A. and Nishimuro S. Jcr Pharmaceut Co Ltd, Biotechnol Res Labs, 3 2 61 Takatsukadai, Nishi Ku, Kobe 65122, Japan
6. Microbial fibrinolytic enzymes: an overview of source, production, properties, and thrombolytic activity in vivo. Applied Microbiology and Biotechnology Vol. 69, No. 2, November, 2005, pp- 126-132
7. Nattokinase for prevention of thrombosis. Am J Health Syst Pharm, 63(12): 1121-3 2006 Tai MW , Sweet BV
8. Effects of nattokinase, a pro-fibrinolytic enzyme, on red blood cell aggregation and whole blood viscosity. Clin Hemorheol Microcirc 2006; 35(1-2):139-42. Pais E, Alexy T, Holsworth RE, Meiselman HJ
9. Thrombolytic Effect of Nattokinase on a Chemically Induced Thrombosis Model in Rat. Biological & Pharmaceutical Bulletin Vol.18 , No.10 (1995) pp.1387-1391 Mitsugu Fujita1, Kyongsu Hong1, Yae Ito1, Rie Fujii2, Kimio KARIYA2 and Satoshi NISHIMURO3
10. Prevention of Venous Thrombosis in Long-Haul Flights with Flite Tabs: The LONFLIT-FLITE Randomized, Controlled Trial Angiology, Vol. 54, No. 5, 531-539 (2003) M.R. Cesarone, et al. 11.Robert Redfern Nutritionalist,Author and broadcaster.
* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any diseases.
All material on this website is for informational purposes only. Nothing contained on this website is intended to be used as a medical diagnosis or treatment. It should not be used in place of the advice of your physician or qualified healthcare provider.
BIOMEDIC LABS, LLC Since 2004 Scientifically Advanced Supplements